Redeye provides its initial take on Genovis’ Q2’22 report, which came in below our expectations. We consider this a rather weak report from Genovis, although we note that the Analytics segment is continuing to grow solidly (+31%).
ANNONS
Redeye provides its initial take on Genovis’ Q2’22 report, which came in below our expectations. We consider this a rather weak report from Genovis, although we note that the Analytics segment is continuing to grow solidly (+31%).